Troy Seelhammer

In a deep dive into anticoagulation management, Troy Seelhammer, an intensivist and co-director of the ECMO program at Mayo Clinic, shares his expertise. He challenges traditional views on the use of heparin, discussing when to be aggressive or conservative with anticoagulants. Conversations about the evolution of heparin-coated cannulas and the potential of bivalirudin add depth. Troy emphasizes the necessity of tailored anticoagulation strategies to enhance patient outcomes while minimizing complications during ECMO therapy.